Caris Life Sciences, Inc. (CAI) stock
CAINasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 8/30131% above fair value
$34.33−1.81 (-5.01%)
Close on Oct 30, 2026Market cap $9.70BP/E –Yield –
Price history
Caris Life Sciences share prices for every month, newest first. Adjusted for stock splits, not for dividends.
Close, Oct 30, 2026
$34.33
-5.01% on the day
52-week range
$14.19 – $36.50
-5.9% from the high
Change over 52 weeks
+10.1%
From $31.17 on Oct 30, 2025
Average volume
4.53M
Shares a day, last 90 sessions
| Month | Open | High | Low | Close | Change | Volume |
|---|---|---|---|---|---|---|
| Oct 2026 | $30.60 | $36.50 | $25.87 | $34.33 | +12.08% | 79,960,093 |
| Sep 2026 | $25.60 | $32.89 | $23.20 | $30.63 | +20.16% | 107,964,414 |
| Aug 2026 | $15.92 | $28.32 | $15.84 | $25.49 | +62.67% | 122,624,443 |
| Jul 2026 | $18.09 | $19.68 | $15.11 | $15.67 | -12.07% | 78,216,975 |
| Jun 2026 | $16.46 | $19.97 | $15.43 | $17.82 | +6.58% | 62,678,453 |
| May 2026 | $18.05 | $20.03 | $14.19 | $16.72 | -12.00% | 65,144,149 |
| Apr 2026 | $18.89 | $22.16 | $17.40 | $19.00 | +6.26% | 36,717,757 |
| Mar 2026 | $19.70 | $20.94 | $16.28 | $17.88 | -11.22% | 60,029,484 |
| Feb 2026 | $22.86 | $23.99 | $17.15 | $20.14 | -13.04% | 45,999,218 |
| Jan 2026 | $27.10 | $29.32 | $23.14 | $23.16 | -14.16% | 53,074,578 |
| Dec 2025 | $25.31 | $29.19 | $25.10 | $26.98 | +5.68% | 56,196,852 |
| Nov 2025 | $30.33 | $31.78 | $22.86 | $25.53 | -15.13% | 32,853,336 |
| Oct 2025 | $30.14 | $33.66 | $28.94 | $30.08 | -0.56% | 15,654,300 |
| Sep 2025 | $37.90 | $38.68 | $28.21 | $30.25 | -21.20% | 14,837,654 |
| Aug 2025 | $27.80 | $42.50 | $27.18 | $38.39 | +36.72% | 14,872,663 |
| Jul 2025 | $26.50 | $33.41 | $25.40 | $28.08 | +5.09% | 12,298,276 |
| Jun 2025 | $27.00 | $30.70 | $25.56 | $26.72 | – | 27,861,040 |